Appetite Support : Helps reduce food cravings and increase satiety
Secondary clinical outcomes Among the individual components of the primary composite outcome, AMI (RRR: 42%, HR: 0.59 [95% CI: 0.38-0.91], P = 0.016) and all-cause mortality (RRR: 44%, HR: 0.35 [95% CI: 0.14-0.89], P = 0.021) were also significantly lower in adults receiving tirzepatide than in those receiving GLP-1RA
This dual approach can be particularly effective for athletes, post-surgical patients, or those with inflammatory bowel disease plus joint pain
30
Freezing causes the water to expand, potentially damaging the peptide structure
This gives it a half-life long enough to support once-weekly dosing, a major practical advantage over earlier amylin-based therapies like pramlintide, which required multiple daily injections